Item 5 of the VS-CMD.

<p>Item 5 of the VS-CMD.</p

Agoraphobia outcomes of VS-CMD item 5 and CIDI. n = 85.

<p>Sensitivity  = .81, specificity  = .66.</p

ROC Curves of VS-CMD item 5, PDSS-SR-4, PDSS-SR-5, and PDSS-SR items 4 and 5 combined.

<p>Footnote: PDSS-SR-4: AUC.684; PDSS-SR-5: AUC.607; PDSS-SR items 4 and 5 combined: AUC.697; VS-CMD item 5: AUC.734.</p

Agoraphobia outcomes of PDSS-SR item 4 and CIDI, cut-off = 2. n = 85.

<p>Sensitivity  = .32, specificity  = .88.</p

Flow chart.

<p>Flow chart.</p

Additional file 1: of Trial for the Prevention of Depression (TriPoD) in final-year secondary students: study protocol for a cluster randomised controlled trial

Completed SPIRIT 2013 checklist of recommended items to address in a clinical trial protocol and related documents. (DOC 121 kb